Ignite Creation Date:
2025-12-25 @ 3:31 AM
Ignite Modification Date:
2026-01-09 @ 1:51 AM
Study NCT ID:
NCT06247605
Status:
RECRUITING
Last Update Posted:
2024-02-08
First Post:
2023-10-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase IIII Study of AL8326 in Small Cell Lung Cancer
Sponsor:
Advenchen Laboratories Nanjing Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AL8326-GB-010
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None